Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Striyker who wrote (2005)	6/28/1998 6:27:00 PM
From: Jim B	Read Replies (1) \| Respond to of 5402

it's a great idea... just needs someone that knows the lingo to call Baxter or Johnson and Johnson to be able to properly communicate what PHER-02 is all about and then maybe see if they have heard of SGNC or would be interested in it... who knows... one phone call is all it takes for a company like Baxter or J&J or the others to find out about SGNC... if they haven't already.. interesting thoughts Striyker... if I was more qualified.. I'd be happy to do it... may do it still... but also surely... word is already spreading with the news of BATTELLE and SGNC... time will tell... good thinking though.. however, I'm with DrDan in believing that is it VERY unlikely that these other R&D and pharma companies would be willing to comment much if anything at all.. other than to say, "Hmmm PHER-02 sounds interesting.. but this kind of product is VERY complicated and would take ALOT of research.. We can't comment at the time.. however, we're always looking into new technologies.. and blood substitutes are one of them"... if we're lucky.. they might even admit to having heard of SGNC.. jim